Cost-effective chronic disease prevention in developing countries
Cost-effective chronic disease prevention in developing countries
批准号:
8846002
负责人:
Jeremy David Goldhaber-Fiebert
金额:
$12.74万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-04-01 至 2016-03-31
关键词:
AccountingAddressAdultAgeAsian IndianBiologicalBiologyBirthCalibrationCaloriesCardiovascular DiseasesCerebrovascular DisordersCessation of lifeChildChildhoodChronicChronic DiseaseCommunicable DiseasesCommunitiesComputersConsumptionCountryDeveloping CountriesDevelopmental ProcessDiabetes MellitusDiabetes preventionDiagnosisDiseaseDisease modelEconometric ModelsEconomicsElderlyEnvironmentEpidemiologyFaceFoodFrail ElderlyHealthHealth BenefitHealth systemHospitalizationHouseholdHuman ResourcesIncidenceIncomeIndiaIndividualInfectionInterventionKnowledgeLifeLife Cycle StagesLightLinkLongitudinal StudiesMalnutritionMentorsMethodsModelingNon-Insulin-Dependent Diabetes MellitusNutrition PolicyNutritionalNutritional statusObesityObesity associated diseaseOutcomePatternPerceptionPersonsPoliciesPovertyPrevalencePreventionPreventive InterventionPricePrimary PreventionProgram EfficiencyPublic HealthReadingRegression AnalysisResearchResearch InfrastructureResearch TrainingResourcesRiskScienceSecondary PreventionSlumSocial PoliciesSubgroupSurveysTaxesTechniquesTimeTrainingTuberculosisUnderweightWorkWorld Health Organizationbasecombatcostcost effectivecost effectivenessdiabeticdisorder controldisorder preventionearly life exposureeconomic impactexperiencehealth economicshigh riskimprovedmodels and simulationnovelnovel strategiesprogramsresponserural areascreeningskillssocioeconomicstransmission process
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Despite the perception that infectious diseases and malnutrition are the main threats to health in the developing world, the reality is that the prevalence of chronic diseases is increasing rapidly. By 2030, chronic diseases are projected to cause more than 40% of deaths in developing countries, prompting a 2008 call from the World Health Organization to establish national action plans for their prevention and control. Such plans must overcome formidable resource constraints. Because chronic diseases overlap with persistent diseases of poverty, policy responses must contend with interacting risks from multiple diseases. For instance, the control of type 2 diabetes through social policies to reduce obesity must avoid exacerbating malnutrition, especially prevalent in children. Conversely, properly targeted diabetes prevention can also reduce tuberculosis prevalence. In countries like India, diabetes' biological link to increased risk of active tuberculosis infection accounts for an estimated 15% of overall tuberculosis incidence. It is, however, not obvious which groups to target as diabetes is more prevalent in middle income groups while tuberculosis is more common in the poor. Current policy assessment methods are insufficient for these problems, as typical analyses focus on the health benefits of addressing a single disease and, therefore, fail to account for important cross-disease effects. A novel approach is required that evaluates the life course benefits of each policy alternative based on its age- and subgroup-specific impact on multiple diseases. This K01 application outlines such an approach. Its training aims are to expand knowledge and skills in: (1) econometric and statistical techniques for analyzing large household surveys, longitudinal studies with non-random attrition, and social policies such as taxes that impact food prices, consumption, and nutritional health outcomes; (2) the life course, developmental processes leading to chronic diseases such as diabetes, cardiovascular and cerebrovascular diseases as well as the biology and epidemiology of persistent diseases of poverty like tuberculosis and malnutrition. This will be accomplished through relevant coursework, mentored directed reading, and seminar participation. This K01 develops specific examples whose logical extension to other countries and diseases indicates far-reaching applicability beyond the scope of the proposal and, hence, high public health significance. The methods developed, though broadly applicable, will be applied to the specific problem of diabetes in India. The specific research aims are: (1) develop a lifetime microsimulation model of type 2 diabetes to assess primary and secondary prevention interventions in Asian Indians; (2) evaluate the impact of nutrition policies on chronic diseases and malnutrition; (3) integrate tuberculosis transmission into the diabetes model to assess how rising diabetes prevalence alters tuberculosis prevalence via their biological interaction; (4) compare the benefits of prevention policies that target subpopulations with different diabetes and tuberculosis risk profiles. In order to determine model inputs, econometric regression and statistical calibration will be used.
期刊论文(27)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
The Costs of Hepatitis C by Liver Disease Stage: Estimates from the Veterans Health Administration.
按肝病阶段划分的丙型肝炎的费用:退伍军人健康管理局的估计。
DOI:
10.1007/s40258-019-00468-5
发表时间:
2019
期刊:
Applied health economics and health policy
影响因子:
3.6
作者:
[Gidwani-Marszowski,Risha, Owens,DouglasK, Lo,Jeanie, Goldhaber-Fiebert,JeremyD, Asch,StevenM, Barnett,PaulG]
通讯作者:
Barnett,PaulG
DOI:
10.1186/1744-8603-7-45
发表时间:
2011-12-16
期刊:
Globalization and health
影响因子:
10.8
作者:
[Chen BK, Seligman B, Farquhar JW, Goldhaber-Fiebert JD]
通讯作者:
Goldhaber-Fiebert JD
Optimal Information Collection Policies in a Markov Decision Process Framework.
马尔可夫决策过程框架中的最优信息收集策略。
DOI:
10.1177/0272989x18793401
发表时间:
2018
期刊:
Medical decision making : an international journal of the Society for Medical Decision Making
影响因子:
--
作者:
[Cipriano,LaurenE, Goldhaber-Fiebert,JeremyD, Liu,Shan, Weber,ThomasA]
通讯作者:
Weber,ThomasA
An Efficient, Noniterative Method of Identifying the Cost-Effectiveness Frontier.
一种识别成本效益边界的高效、非迭代方法。
DOI:
10.1177/0272989x15583496
发表时间:
2016
期刊:
Medical decision making : an international journal of the Society for Medical Decision Making
影响因子:
--
作者:
[Suen,Sze-chuan, Goldhaber-Fiebert,JeremyD]
通讯作者:
Goldhaber-Fiebert,JeremyD
DOI:
10.1371/journal.pmed.1002532
发表时间:
2018-03
期刊:
PLoS medicine
影响因子:
15.8
作者:
[Lin E, Chertow GM, Yan B, Malcolm E, Goldhaber-Fiebert JD]
通讯作者:
Goldhaber-Fiebert JD
共 16 条
Cost-effective chronic disease prevention in developing countries
-
批准号:8437194
-
项目类别:
-
资助金额:$12.74万
-
财政年份:2011
-
负责人:Jeremy David Goldhaber-Fiebert
-
依托单位:
Cost-effective chronic disease prevention in developing countries
-
批准号:8658787
-
项目类别:
-
资助金额:$12.74万
-
财政年份:2011
-
负责人:Jeremy David Goldhaber-Fiebert
-
依托单位:
Cost-effective chronic disease prevention in developing countries
-
批准号:8112762
-
项目类别:
-
资助金额:$12.74万
-
财政年份:2011
-
负责人:Jeremy David Goldhaber-Fiebert
-
依托单位:
Cost-effective chronic disease prevention in developing countries
-
批准号:8244442
-
项目类别:
-
资助金额:$12.74万
-
财政年份:2011
-
负责人:Jeremy David Goldhaber-Fiebert
-
依托单位:
海外基金